Outlook Therapeutics logo
Outlook Therapeutics OTLK
$ 5.16 -2.27%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Outlook Therapeutics EV/EBITDA Ratio 2011-2024 | OTLK

Annual EV/EBITDA Ratio Outlook Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.04 -1.36 -1.17 -1.95 -1.42 -1.56 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.17 -3.04 -1.75